23:56:48 EDT Mon 13 Jul 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:TRIL from 2019-07-14 to 2020-07-13 - 40 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2020-07-06 09:24C:TRILTrillium Therapeutics Inc (2)10.63News ReleaseTrillium shareholders elect six directors at AGM
2020-05-29 09:56C:TRILTrillium Therapeutics Inc (2)News ReleaseTrillium releases data from phase 1 TTI-662 study
2020-05-15 17:08C:TRILTrillium Therapeutics Inc (2)8.11News ReleaseTrillium Therapeutics spends $4.3M (U.S.) on Q1 R&D
2020-05-15 17:05C:TRILTrillium Therapeutics Inc (2)8.11SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-05-15 17:05C:TRILTrillium Therapeutics Inc (2)8.11SEDAR MD & ASEDAR MD & A
2020-05-06 09:19C:TRILTrillium Therapeutics Inc (2)7.45News ReleaseTrillium arranges $50M at-the-market program
2020-04-08 07:33C:TRILTrillium Therapeutics Inc (2)5.90News ReleaseTrillium expects pause or slowdown in patient enrolment
2020-03-20 10:37C:TRILTrillium Therapeutics Inc (2)4.35Resume TradingTrillium Therapeutics to resume at 7:27 a.m. PT
2020-03-20 10:36C:TRILTrillium Therapeutics Inc (2)4.35Halt TradingTrillium Therapeutics halted at 7:22 a.m. PT
2020-03-10 07:16C:TRILTrillium Therapeutics Inc (2)7.68SEDAR Annual Information FormSEDAR Annual Information Form
2020-03-10 07:16C:TRILTrillium Therapeutics Inc (2)7.68SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2020-03-10 07:10C:TRILTrillium Therapeutics Inc (2)7.68SEDAR MD & ASEDAR MD & A
2020-03-10 07:05C:TRILTrillium Therapeutics Inc (2)7.54News ReleaseTrillium spends $27.17M (U.S.) on R&D in 2019
2020-02-28 12:42C:TRILTrillium Therapeutics Inc (2)4.56Resume TradingTrillium Therapeutics to resume at 10 a.m. PT
2020-02-28 12:39C:TRILTrillium Therapeutics Inc (2)4.56News ReleaseTrillium does not say why stock is up
2020-02-28 12:28C:TRILTrillium Therapeutics Inc (2)4.56Halt TradingTrillium Therapeutics halted at 9:25 a.m. PT
2020-02-28 11:14C:TRILTrillium Therapeutics Inc (2)4.56Resume TradingTrillium Therapeutics to resume at 8:16 a.m. PT
2020-02-28 11:13C:TRILTrillium Therapeutics Inc (2)4.56Halt TradingTrillium Therapeutics halted at 8:11 a.m. PT
2020-02-28 09:53C:TRILTrillium Therapeutics Inc (2)4.56Halt TradingTrillium Therapeutics halted at 6:50 a.m. PT
2020-02-28 09:52C:TRILTrillium Therapeutics Inc (2)4.56Resume TradingTrillium Therapeutics to resume at 6:55 a.m. PT
2020-02-07 07:50C:TRILTrillium Therapeutics Inc (2)5.00News ReleaseTrillium Therapeutics appoints Walker to board
2020-01-29 07:12C:TRILTrillium Therapeutics Inc (2)5.85News ReleaseTrillium closes $116.95-million (U.S.) financing
2020-01-24 21:15C:TRILTrillium Therapeutics Inc (2)5.90Prospectus ApprovedTrillium to list 35,731,818 more shares Jan. 28
2020-01-23 08:40C:TRILTrillium Therapeutics Inc (2)5.56News ReleaseTrillium prices equity raise at $2.75 (U.S.) a share
2020-01-22 16:18C:TRILTrillium Therapeutics Inc (2)4.28News ReleaseTrillium arranges public offering of shares, preferreds
2020-01-16 09:14C:TRILTrillium Therapeutics Inc (2)3.67News ReleaseTrillium regains compliance with Nasdaq bid price rule
2020-01-07 09:43C:TRILTrillium Therapeutics Inc (2)1.51News ReleaseTrillium increases dosing for TTI-621 program
2019-11-14 08:19C:TRILTrillium Therapeutics Inc (2)0.375News ReleaseTrillium loses $29.77M in first nine months of 2019
2019-11-14 07:15C:TRILTrillium Therapeutics Inc (2)0.375SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-11-14 07:15C:TRILTrillium Therapeutics Inc (2)0.375SEDAR MD & ASEDAR MD & A
2019-10-22 09:23C:TRILTrillium Therapeutics Inc (2)0.365News ReleaseTrillium to discontinue discovery research activities
2019-10-22 09:06C:TRILTrillium Therapeutics Inc (2)0.365Resume TradingTrillium Therapeutics to resume at 6:50 a.m. PT
2019-10-22 08:56C:TRILTrillium Therapeutics Inc (2)0.365Halt TradingTrillium Therapeutics halted at 5:54 a.m. PT
2019-10-08 07:43C:TRILTrillium Therapeutics Inc (2)0.385News ReleaseTrillium given +180 days to comply with Nasdaq rules
2019-09-25 07:34C:TRILTrillium Therapeutics Inc (2)0.54News ReleaseTrillium appoints Skvarka as president, CEO
2019-09-05 09:03C:TRILTrillium Therapeutics Inc (2)0.38News ReleaseTrillium to present at investor conference Sept. 10
2019-08-13 09:37C:TRILTrillium Therapeutics Inc (2)0.405SEDAR MD & ASEDAR MD & A
2019-08-13 09:30C:TRILTrillium Therapeutics Inc (2)0.405SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2019-08-13 08:08C:TRILTrillium Therapeutics Inc (2)0.405News ReleaseTrillium loses $17.17-million in first half of 2019
2019-07-24 07:57C:TRILTrillium Therapeutics Inc (2)0.45News ReleaseTrillium to meet with FDA later this quarter